These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7805990)

  • 1. Endometrial polyps, cystic glandular hyperplasia and atypical leiomyoma associated with tamoxifen therapy.
    Kimya Y; Cengiz C; Tolunay S
    Int J Gynaecol Obstet; 1994 Jul; 46(1):69-70. PubMed ID: 7805990
    [No Abstract]   [Full Text] [Related]  

  • 2. Gynaecological complications of women treated with tamoxifen for breast cancer.
    Dew JE; Eden JA
    Aust N Z J Obstet Gynaecol; 1995 May; 35(2):198-200. PubMed ID: 7677689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen.
    Ugwumadu AH; Harding K
    Eur J Obstet Gynecol Reprod Biol; 1994 Apr; 54(2):153-6. PubMed ID: 8070603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding.
    Fotiou S; Tserkezoglou A; Hadjieleftheriou G; Apostolikas N; Karydas I; Stravolemos K
    Anticancer Res; 1998; 18(1B):625-9. PubMed ID: 9584044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endometrial pathologies associated with postmenopausal tamoxifen treatment.
    Cohen I
    Gynecol Oncol; 2004 Aug; 94(2):256-66. PubMed ID: 15297160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Uterine abnormalities in non menopausal women who received tamoxifen for breast cancer adjuvant therapy].
    d'Arailh AS; Michy T; Pioud R; Dravet F; Classe JM
    Gynecol Obstet Fertil; 2007 Dec; 35(12):1215-9. PubMed ID: 18035581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does tamoxifen induce endometrial hyperplasia, carcinoma and polyps?
    van den Bosch T; Vandendael A
    S Afr Med J; 1994 Jun; 84(6):367-8. PubMed ID: 7740401
    [No Abstract]   [Full Text] [Related]  

  • 8. Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer.
    Deligdisch L; Kalir T; Cohen CJ; de Latour M; Le Bouedec G; Penault-Llorca F
    Gynecol Oncol; 2000 Aug; 78(2):181-6. PubMed ID: 10926800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign and malignant diseases of the endometrium.
    Chaudhry S; Reinhold C; Guermazi A; Khalili I; Maheshwari S
    Top Magn Reson Imaging; 2003 Aug; 14(4):339-57. PubMed ID: 14578778
    [No Abstract]   [Full Text] [Related]  

  • 10. Endometrial tubal metaplasia in a young puerperal woman after breast cancer.
    Di Benedetto L; Giovanale V; Caserta D
    Int J Clin Exp Pathol; 2015; 8(6):7610-3. PubMed ID: 26261678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy.
    McGonigle KF; Shaw SL; Vasilev SA; Odom-Maryon T; Roy S; Simpson JF
    Am J Obstet Gynecol; 1998 Jun; 178(6):1145-50. PubMed ID: 9662294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of Endometrial Polyps, Hyperplasia, Carcinoma, and Uterine Cancer After Tamoxifen Treatment in Premenopausal Women With Breast Cancer.
    Ryu KJ; Kim MS; Lee JY; Nam S; Jeong HG; Kim T; Park H
    JAMA Netw Open; 2022 Nov; 5(11):e2243951. PubMed ID: 36441547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
    Liu IF; Yen YS; Cheng YM; Chou CY
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic pitfalls of ultrasonographic uterine screening in women treated with tamoxifen.
    Bornstein J; Auslender R; Pascal B; Gutterman E; Isakov D; Abramovici H
    J Reprod Med; 1994 Sep; 39(9):674-8. PubMed ID: 7807477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the inhibin/activin subunits alpha (alpha), beta-A (betaA) and beta-B (betaB) in benign human endometrial polyps and tamoxifen-associated polyps.
    Mylonas I; Makovitzky J; Fernow A; Richter DU; Jeschke U; Briese V; Gerber B; Friese K
    Arch Gynecol Obstet; 2005 Jun; 272(1):59-66. PubMed ID: 15309402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progesterone receptor expression in postmenopausal tamoxifen-exposed endometrial pathologies.
    Cohen I; Beyth Y; Altaras MM; Shapira J; Tepper R; Cardoba M; Yigael D; Figer A; Fishman A; Berenhein J
    Gynecol Oncol; 1997 Oct; 67(1):8-15. PubMed ID: 9345349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women.
    Chan SS; Tam WH; Yeo W; Yu MM; Ng DP; Wong AW; Kwan WH; Yuen PM
    BJOG; 2007 Dec; 114(12):1510-5. PubMed ID: 17995495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathology of endometrium treated with tamoxifen.
    Ismail SM
    J Clin Pathol; 1994 Sep; 47(9):827-33. PubMed ID: 7962652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial polyps in postmenopausal patients receiving tamoxifen.
    Nuovo MA; Nuovo GJ; McCaffrey RM; Levine RU; Barron B; Winkler B
    Int J Gynecol Pathol; 1989; 8(2):125-31. PubMed ID: 2714930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.